Site Announcement
For the latest results and update on CytoDyn’s Phase 2 CRC trial and more, here’s a link to our April 30, 2026 investor update webinar
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 12/22/11 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 12/21/11 | 3 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 12/20/11 | 8-K | Current report filing |
|
5 | |
| 12/05/11 | SC 13D | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
5 | |
| 12/05/11 | SC 13D | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
5 | |
| 11/30/11 | 10-Q/A | Quarterly report pursuant to sections 13 or 15(d) |
|
   |
5 |
| 11/22/11 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
23 | |
| 11/16/11 | 8-K | Current report filing |
|
24 | |
| 11/10/11 | 8-K | Current report filing |
|
18 | |
| 11/03/11 | 4/A | F-4MEF |
|
2 |
